2025-523553-34-00招募中1 期
A Phase 1a/1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of BG-75202, Alone and in Combination with Other Agents in Patients with Advanced Solid Tumors
BeOne Medicines I GmbH9 个研究点 分布在 2 个国家目标入组 15 人开始时间: 2026年4月1日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 15
- 试验地点
- 9
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
BeOne Medical Officer
Scientific
BeOne Medicines I GmbH
研究点 (9)
Loading locations...
相似试验
招募中
2 期
A Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION717 in Patients with Prion Disease2023-503355-98-00Ionis Pharmaceuticals Inc.8
招募中
1 期
A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid TumorsNCT07376707Hefei TG ImmunoPharma Co., Ltd.194
尚未招募
1 期
First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.NCT07377253Giuseppe Pantaleo18
招募中
1 期
A phase I trial evaluating the safety, tolerability, and pharmacokinetic profile of INP12 in patients with advanced solid tumors.2024-518126-32-00Innoup Farma S.L.70
招募中
1 期
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B CirrhosisNCT07413549Beijing Tuohua Weiye Biotechnology Co., Ltd.76